Skip to main content
SpringerLink
Log in

A family history study of schizophrenia spectrum disorders suggests new candidate genes in schizophrenia and autism

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

To limit genetic heterogeneity, this study focused on the widely extended pedigrees of Ashkenazi Jewish schizophrenic and autistic probands, to determine if similar causal mechanisms might obtain for both conditions. At least two previous epidemiological studies have demonstrated increased risk for schizophrenia in Ashkenazi Jews. The hypothesis posed is that increased prevalence of various rare autosomal recessive diseases among the Ashkenazim might contribute to the increased vulnerability to schizophrenia and to autism in this large genetic isolate. Rates of amyotrophic lateral sclerosis (ALS) and bleeding disorders were significantly increased among relatives of schizophrenic and autistic probands, compared to relatives of normal probands. These results suggest new candidate loci in schizophrenia and autism, particularly the chromosome 15q23-24 locus of the hexosaminidase A gene, causing various GM2 gangliosidoses, and the 21q22.1–q22.2 loci of the antioxidant, superoxide dismutase gene, and a cytokine receptor gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goodman, AB. Medical conditions in Ashkenazi schizophrenic pedigress. Schizophrenia Bulletin, 20(3):1994.

  2. Rahav M, Goodman AB, Popper M, et al. Distribution of treated mental illness in the neighborhoods of Jerusalem. American Journal of Psychiatry, 143 (10):1249–1254, 1986.

    CAS  PubMed  Google Scholar 

  3. Dohrenwend BP, Levav I, Shrout PE, et al. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science, 255:946–952, 1992.

    CAS  PubMed  Google Scholar 

  4. Neel JV. History and the Tay-Sachs Allele, in: Genetic Diseases Among Ashkenazi Jews, Edited by Goodman RM, Motulsky AG, New York, Raven Press, 285–299, 1979.

    Google Scholar 

  5. Jorde LB. Genetic Diseases in the Ashkenazi Population: Evolutionary Considerations, in Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. Edited by Bonne-Tamir B, Adam A. New York, Oxford University Press, 305–318, 1992.

    Google Scholar 

  6. Bonne-Tamir A, Adam A. Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. Edited by Bonne-Tamir B, Adam A. New York, Oxford University Press, 1992.

    Google Scholar 

  7. Sandhoff K, Conzelmann E, Neufeld EF, et al. The GM2 gangliosidoses, in The Metabolic Basis of Inherited Disease, 6th ed, vol 2. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. McGraw Hill, New York 1807–1839, 1989.

    Google Scholar 

  8. Barranger JA, Ginns EI. Glucosylceramide lipidoses: Gaucher Disease, in The Metabolic Basis of Inherited Disease, 6th ed, vol 2. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. McGraw Hill, New York, 1677–1698, 1989.

    Google Scholar 

  9. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry, 145(12):11–18, 1988.

    CAS  PubMed  Google Scholar 

  10. Woods, BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families: I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Archives of General Psychiatry, 43:657–664, 1986.

    CAS  PubMed  Google Scholar 

  11. Kinney DK, Woods BT, Yyrgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families: II. Neurologic and psychiatric findings in relatives. Archives of General Psychiatry, 43:665–688, 1986.

    CAS  PubMed  Google Scholar 

  12. Idanpaan-Heikkila J, Alhava E, Olkinuora M, et al. Agranulocytosis during treatment with clozapine. European Journal of Clinical Pharmacology 11:193–198, 1977.

    CAS  PubMed  Google Scholar 

  13. Lieberman JA, Yunis J, Egea E, et al. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Archives of General Psychiatry, 47:945–948, 1990.

    CAS  PubMed  Google Scholar 

  14. Cannon TD, Mednick SA, Parnas J. Genetic and perinatal determinants of structural brain deficits in schizophrenia. Archives of General Psychiatry, 465:883–889, 1989.

    Google Scholar 

  15. Thompson WD, Kidd JR, Weissman MM. A procedure for the efficient collection and processing of pedigree data suitable for genetic analysis. Journal of Psychiatric Research, 15:291–303, 1980.

    Google Scholar 

  16. DeLisi LE, Goldin LR, Maxwell E, et al. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 44:891–896, 1987.

    CAS  PubMed  Google Scholar 

  17. Ridley RM, Baker HF. Variable expression in the functional psychoses, a comparison with Huntington's disease. Schizophrenia Research, 3:201–210, 1990.

    Article  CAS  PubMed  Google Scholar 

  18. Blackwood D, St. Clair D, Muir W, et al. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Archives of General Psychiatry. 48(10):899–909, 1991.

    CAS  PubMed  Google Scholar 

  19. Slater E, Cowie V. The Genetics of Mental Disorders. Appendix C:353–354. Oxford University Press, New York, 1971.

    Google Scholar 

  20. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods, Belmont, California; Wadsworth, Inc. 1982.

    Google Scholar 

  21. Goodman AB, Brothers AM, Ritvo E. Familial co-occurrence of amyotrophic lateral sclerosis and schizophrenia in autistic pedigrees. Submitted for publication.

  22. Annegers JF, Appel S, Lee J R-J, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985–1988. Archives of Neurology 48:589–593, 1991.

    CAS  PubMed  Google Scholar 

  23. Goodman AB. Hypothesis: gangliosides in schizophrenia. Submitted for publication.

  24. Goodman AB. Retinoid disregulation as a cause of schizophrenia. Letter to the Editor. American Journal of Psychiatry, 151(3):452–453, 1994.

    CAS  PubMed  Google Scholar 

  25. Goodman AB. Elevated risks for amyotrophic lateral sclerosis and blood disorders in Ashkenazi schizophrenic pedigrees suggest new candidate genes in schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54:1994.

  26. Siddique T, Figlewics DA, Pericakk-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. New England Journal of Medicine 324:1381–1384, 1991.

    CAS  PubMed  Google Scholar 

  27. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362:59–62, 1993.

    Article  CAS  PubMed  Google Scholar 

  28. Howland RH. Schizophrenia and amyotrophic latera sclerosis. Comprehensive Psychiatry, 31(4):327–336, 1990.

    Article  CAS  PubMed  Google Scholar 

  29. Diaz-Arrastia R, Younger DS, Hair L, et al. Neurolymphomatosis: a clinico-pathologic syndrome re-emerges. Neurology, 42:1136–1141, 1992.

    CAS  PubMed  Google Scholar 

  30. Mehler MF, Rozental R, Dougherty M, Spray DC, Kessler JA. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362:62–65, 1993.

    Article  CAS  PubMed  Google Scholar 

  31. Straub RE, Lehner T, Loth JE, et al. Linkage analysis of bipolar affective disorder: summary of genomic screening results and positive lod scores with markers in region 21q22.3 in one large family. Psychiatric Genetics 3(3):124, 1993.

    Google Scholar 

  32. DeBruyn A, Mendelbaum K, Sandkuijl LA, et al. Linkage studies with bipolar disorder in two Belgian families. Psychiatric Genetics 3:124, 1993.

    Google Scholar 

  33. Smith CA, Gruss HJ, Davis T, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73(7):1349–60, 1993.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nathan S. Kline Institute for Psychiatric Research, 10962, Orangeburg, NY

    Ann B. Goodman M.A., M.S.

Authors
  1. Ann B. Goodman M.A., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodman, A.B. A family history study of schizophrenia spectrum disorders suggests new candidate genes in schizophrenia and autism. Psych Quart 65, 287–297 (1994). https://doi.org/10.1007/BF02354305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02354305

Keywords

Search

Navigation